Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-03-07FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for memantine hydrochloride submitted by Actavis Pharma, Inc. under NDA. The action finalizes ch…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial evaluating a vitamin/nutriceutical formulation for Alzheimer's disease and mild cognitive impairment has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: New Approach for Treatment of Behavioral Disorders in Alzheimer's Disease (Alzheimer's Behavioral and Cognitive Disorders) [NA]
Clinical trial update for a new approach to treating behavioral disorders in Alzheimer's disease; study completed with results posted in 201…
-
FDA approval · 2016-02-26FDA Approved: FLUDEOXYGLUCOSE F 18 — Supplemental Application (Massachusetts General Hospital)
FDA approved a supplemental application for Fludeoxyglucose F-18 submitted by Massachusetts General Hospital to support its use as a radioph…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease [Phase 2]
A Phase 2 study evaluating amyloid imaging and safety of ACC-001 in subjects with early Alzheimer's disease was completed, with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease [Phase 1, Phase 2]
Clinical trial update on the safety and potential efficacy of umbilical cord-derived mesenchymal stem cells for Alzheimer's disease in Phase…
-
FDA approval · 2016-02-19FDA Approved: MEMANTINE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for memantine submitted by NorthStar RxLLC (ANDA090048).
-
FDA approval · 2016-02-19FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Edenbridge Pharmaceuticals LLC.)
The FDA approved Edenbridge Pharmaceuticals LLC's generic donepezil hydrochloride product (Original Application), making a generic version o…
-
CLINICAL_TRIALS other · 2016-02-19Clinical Trial Update: Early Counseling and Support for Alzheimer's Disease Caregivers [NA]
This entry provides a clinical trial update on early counseling and support for caregivers of people with Alzheimer's disease, with no resul…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: 24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion [Phase 2]
Pharnext reports the completion of a 24-week open-label extension study evaluating PXT00864 in mild Alzheimer's disease after completion of …
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Dose Response Study of Aerobic Exercise in Older Adults [EARLY_Phase 1]
Results from an early-phase dose-response study of aerobic exercise in older adults with Alzheimer's disease have been posted following tria…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD) [Phase 2]
A Phase 2 pilot study evaluating PXT00864 in patients with mild Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Bexarotene Amyloid Treatment for Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating bexarotene as an amyloid-targeting treatment for Alzheimer's disease has completed, with results posted in…
-
CLINICAL_TRIALS withdrawal · 2016-02-09Clinical Trial Update: The Role of Mid-Life Adiposity in Functional Brain Connectivity
A clinical trial investigating the effect of mid-life adiposity on functional brain connectivity related to Alzheimer’s disease has been ter…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: FluoroAv45 Imaging Research-in Alzheimer's Disease [Phase 2]
Phase 2 imaging trial using FluoroAv45 in Alzheimer's disease and mild cognitive impairment has completed.
-
CLINICAL_TRIALS withdrawal · 2016-02-04Clinical Trial Update: Using Hypnotherapy For Dementia & Alzheimer's
A clinical trial studying hypnotherapy for dementia and Alzheimer's disease is no longer available.
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of multiple ascending doses of GC021109 in adults with mild to moderate …
-
EMA guidance · 2016-02-01Consultation on revised guideline on medicines to treat Alzheimer's disease
EMA consulted on revised guideline for medicines to treat Alzheimer's disease, outlining proposed recommendations for development, evidence,…
-
CLINICAL_TRIALS research · 2016-01-27Clinical Trial Update: The Trinity, Ulster and Department of Agriculture Cohort Study
A clinical trial update for the Trinity, Ulster and Department of Agriculture Cohort Study led by the University of Ulster; the trial status…
-
FDA approval · 2016-01-25FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
FDA approved a supplemental application for NEURACEQ (Florbetaben F-18) by Lantheus Biosciences Ltd., supporting its use as a PET imaging ag…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: " The Eyes Have it " : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease
This clinical trial update reports on ocular saccade abnormalities observed in prodromal Alzheimer's disease and notes that the study has co…
-
CLINICAL_TRIALS research · 2016-01-20Clinical Trial Update: Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease
This clinical trial update describes research into detecting disease-related changes in individuals who are pre-symptomatic for Alzheimer's …
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres [NA]
A completed clinical trial evaluating group therapy for caregivers of Alzheimer's disease patients in Spanish elderly care centers.
-
CLINICAL_TRIALS withdrawal · 2016-01-14Clinical Trial Update: A Composite MR Neuroimaging Marker for Alzheimer's Disease
The clinical trial evaluating a composite MR neuroimaging marker for Alzheimer's disease and related cognitive impairment has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose) [Phase 1]
Phase 1 single-ascending-dose study of NGP 555 in healthy young volunteers has completed. The trial assessed safety and tolerability for Neu…